awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50096157-AD0ABAB0-BD4D-4568-B6B2-69D5876DE27A
Q50096157-AD0ABAB0-BD4D-4568-B6B2-69D5876DE27A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50096157-AD0ABAB0-BD4D-4568-B6B2-69D5876DE27A
Short-term outcomes of patients with type 2 diabetes mellitus treated with canagliflozin compared with sitagliptin in a real-world setting.
P2860
Q50096157-AD0ABAB0-BD4D-4568-B6B2-69D5876DE27A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50096157-AD0ABAB0-BD4D-4568-B6B2-69D5876DE27A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4e6ee04e996281e6ad0cadca67a643b5c76a8add
P2860
Canagliflozin: a novel treatment option for type 2 diabetes.